TP53 Gene Polymorphisms in Cancer Risk: The Modulating Effect of Ageing, Ethnicity and TP53 Somatic Abnormalities

QR Code

TP53 Gene Polymorphisms in Cancer Risk: The Modulating Effect of Ageing, Ethnicity and TP53 Somatic Abnormalities

None

Saved in:

Bibliographic Details
Main Authors:	Denisov, Evgeny V., Cherdyntseva, Nadezhda V., Litviakov, Nicolay V., Malinovskaya, Elena A., Babyshkina, Natalya N., Belyavskaya, Valentina A., Voevoda, Mikhail I.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/27564
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

New mutation of the TP53 gene associated with the hereditary breast cancer in a young Tuvinian woman
by: P. A. Gervas, et al.
Published: (2022-01-01)

POLYMORPHISM OF THE TP53 GENE IN PATIENTS WITH GASTRIC CANCER IN PROSPECTIVE AND CLINICAL CASE-CONTROL STUDIES
by: A. V. Belkovets, et al.
Published: (2018-07-01)

CLINICAL SIGNIFICANCE OF THE TP53 MUTATION STATUS IN DIFFUSE LARGE B-CELL LYMPHOMA
by: E. N. Voropaeva, et al.
Published: (2019-03-01)

TP53-dependence on the effect of doxorubicin and Src inhibitor combination therapy
by: Yun Sun Lee, et al.
Published: (2018-08-01)

CASES OF DIFFUSE LARGE B-CELL LYMPHOMA WITH FUNCTIONAL INTRON MUTATIONS IN THE TP53 GENE
by: E. N. Voropaeva, et al.
Published: (2020-03-01)

TP53 alteration determines the combinational cytotoxic effect of doxorubicin and an antioxidant NAC
by: Yun Sun Lee, et al.
Published: (2017-06-01)

The Critical Role of TP53 in Developing Leukaemia in Human and Dogs, Review Article
by: ِAoula Al-Zebeeby, et al.
Published: (2025-06-01)

Asynchronous replication of AURKA and TP53 genes in gastric cancer patients and patients with multiple tumors
by: V. V. Tsepenko, et al.
Published: (2019-07-01)

Characteristics predicting reduced penetrance variants in the high-risk cancer predisposition gene TP53
by: Cristina Fortuno, et al.
Published: (2025-10-01)

TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis
by: Jin Li, et al.
Published: (2025-01-01)

A novel germline mutation of TP53 with breast cancer diagnosed as Li–Fraumeni syndrome
by: Masaya Kai, et al.
Published: (2022-10-01)

Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations
by: Anmol Baranwal, et al.
Published: (2025-07-01)

Study of the TP53 codon 72 polymorphism in oral cancer and oral potentially malignant disorders in Argentine patients
by: Ana Maria Zarate, et al.
Published: (2017-04-01)

Investigating the Anticancer Potential of Chitosan Nanoparticles: In Vitro Assessment on TP-53 and PC-3 Cell Lines
by: Sama Jawad Al-Zuwaini, et al.
Published: (2025-04-01)

Correction: TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis
by: Jin Li, et al.
Published: (2025-06-01)

Association of polymorphism <i>TP53</i> Arg72Pro with radon-induced lung cancer in the Kazakh population
by: O. Bulgakova, et al.
Published: (2019-08-01)

Rezatapopt: A promising small-molecule “refolder” specific for TP53Y220C mutant tumors
by: Kostas A. Papavassiliou, et al.
Published: (2025-09-01)

NAMPT haploinsufficiency is a collateral lethal therapeutic vulnerability in high-risk myeloid malignancies with TP53 inactivation
by: Madhavi D. Senagolage, et al.
Published: (2025-08-01)

Contribution of TP53 and MDM4 Genetic Polymorphisms as a Risk Factor in Non-Hodgkin Lymphoma in Adult Egyptian Patients
by: Eman A Helal, et al.
Published: (2025-07-01)

Lack of association of the TP53BP1 Glu353Asp polymorphism with risk of cancer: a systematic review and meta-analysis.
by: Lei Liu, et al.
Published: (2014-01-01)

Long‐term follow‐up and combined Phase 2 results of eprenetapopt and azacitidine in patients with TP53 mutant MDS/AML
by: David A. Sallman, et al.
Published: (2025-07-01)

The cell cycle regulatory gene polymorphisms TP53 (rs1042522) and MDM2 (rs2279744) in lung cancer: a meta-analysis
by: O. Bulgakova, et al.
Published: (2020-12-01)

Metastatic small cell lung cancer arises from TP53/RB1-deficient and MYC overproduction hESC-derived PNECs
by: Huanhuan Joyce Chen, et al.
Published: (2025-07-01)

Цитогенетические повреждения и эпигенетический статус промоторов генов TP53, BRCA1 и ERCC2 у работников угольных предприятий
by: Марущак А.В, et al.
Published: (2025-07-01)

The Association between Single Nucleotide Polymorphisms rs1042522 and rs1642785 in the TP53 gene and Acute Myeloid leukemia in a sample of the Baghdad/ Iraq population
by: Hadeel Hameed Dawood, et al.
Published: (2024-03-01)

DNA Methylation of iNOS, eNOS, TP53 and LINE‐1 in Gingival Tissues of Cigarette Smokers, Heat‐Not‐Burn Smokers and Never Smokers: An Exploratory Study
by: Giulio Rasperini, et al.
Published: (2025-06-01)

Treatment outcomes for patients with newly diagnosed or relapsed/refractory TP53-mutated mantle cell lymphoma: a systematic review and meta-analysisResearch in context
by: Na Zhang, et al.
Published: (2025-07-01)

<i>TP53</i> Is a Potential Target of Juglone Against Colorectal Cancer: Based on a Combination of Molecular Docking, Molecular Dynamics Simulation, and In Vitro Experiments
by: Yunting Deng, et al.
Published: (2025-06-01)

Stomatobaculum longum-Derived Extracellular Vesicles Enhance Oral Squamous Cell Carcinoma Malignancy Through BRCA1/EXO1/TP53BP1 Modulation
by: Yan L, et al.
Published: (2025-05-01)

Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing–based cohort study
by: Mayank Jauhri, et al.
Published: (2017-02-01)

Molecular Mechanisms of <i>Lobelia nummularia</i> Extract in Breast Cancer: Targeting EGFR/TP53 and PI3K-AKT-mTOR Signaling via ROS-Mediated Apoptosis
by: Fahu Yuan, et al.
Published: (2025-07-01)

Germline TP53 p.R337H and XAF1 p.E134* Variants: Prevalence in Paraguay and Comparison with Rates in Brazilian State of Paraná and Previous Findings at the Paraguayan–Brazilian Border
by: Edith Falcon-de Legal, et al.
Published: (2025-06-01)

Value of constitutional polymorphisms gene <i>р53</i> at patients with non-Hodgkin’s lymphomas
by: T. I. Pospelova, et al.
Published: (2008-12-01)

Opto-p53: A light-controllable activation of p53 signaling pathway
by: Tatsuki Tsuruoka, et al.
Published: (2025-06-01)

Association of polymorphic markers of the <i>XRCC1</i>, <i>ERCC5</i>, <i>TP53</i>, <i>CDKN1A1</i> genes with the survival of patients after platinum-based chemotherapy for triple negative breast cancer
by: T. M. Zavarykina, et al.
Published: (2023-05-01)

The role of aTp-dependent chromatin remodeling factors in chromatin assembly in vivo
by: Iu. A. Il’ina, et al.
Published: (2019-03-01)

Corrigendum to “Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors” [Eur. Urol. Open Sci. 70 (2024) 86–90]
by: Marta Garcia de Herreros, et al.
Published: (2025-07-01)

THE UNIVERSALIZATION OF CAD TP SHAPED CASTING BASED ON A NODAL CALCULATION OF SOLI- DIFICATION OF CASTINGS
by: A. F. Smykov, et al.
Published: (2013-09-01)

Genetic mapping and expressivity of a wheat multi-pistil gene in mutant 12TP
by: Xin-xin ZHU, et al.
Published: (2019-03-01)

Optimizing the Hexagonal Fuzzy Transportation Problem With the Novel Dhouib-Matrix-TP1 Method
by: Souhail Dhouib, et al.
Published: (2025-01-01)